Last reviewed · How we verify
NCT03942471
Mindfulness for Adolescents With Type 1 Diabetes
NA trial testing Mindfulness Based Stress Reduction in Type 1 Diabetes Mellitus in 65 participants. Completed in 5 January 2019.
1 October 2018
Quick facts
| Lead sponsor | Duquesne University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 65 |
| Start date | 14 October 2015 |
| Primary completion | 1 October 2018 |
| Estimated completion | 5 January 2019 |
Drugs / interventions tested
- Mindfulness Based Stress Reduction
Conditions studied
- Type 1 Diabetes Mellitus — all drugs for Type 1 Diabetes Mellitus →
Sponsor
Duquesne University
Who can join
Adults 12 to 19, any sex, with Type 1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adolescents with Type 1 Diabetes will be invited to the Mindfulness study. They will be randomly assigned to a Control or Active Group. The Active Group will learn Mindfulness Based Stress Reduction (MBSR) through an online website designed to teach the basic principles of MBSR in six week-long modules. They will be measured in three main areas: before learning the intervention, directly after learning it and 3 months after learning it to determine any changes in their Mindful attention awareness, Diabetes Quality of Life and HbA1c. The Control Group will also take the questionnaires at the beginning of the study, 6 weeks after it begins and then 3 months from the beginning to obtain data for all three time points when they have not received access to the modules/intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03942471
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Based Stress Reduction
Trials testing the same drug.
- NCT04980612 — Development and Feasibility of Mindfulness Based Pain Reduction · NA · active not recruiting
- NCT05100537 — Effect of Mindfulness Based Stress Reduction (MBSR) Programme for Reducing the Stress Level of Nursing Student · NA · completed
- NCT05541263 — Mindful Network Dynamics Regulation Under Stress · NA · terminated
- NCT04016415 — Decreasing Stress in Diabetes · NA · completed
- NCT04625777 — Selah Trial of Stress Interventions for Clergy: Mindfulness Based Stress Reduction, Daily Examen, and Stress Inoculation · NA · completed
Other recruiting trials for Type 1 Diabetes Mellitus
Currently open trials in the same condition.
- NCT07142252 — Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus · Phase 2 · recruiting
- NCT07296276 — Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM · NA · recruiting
- NCT07409701 — Gamification Intervertion in Children With Type 1 Diabetes · NA · recruiting
- NCT07356089 — Twiist Postmarket Surveillance Study for Type 1 Diabetes · recruiting
- NCT07434154 — Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults · recruiting
Other Duquesne University trials
Trials by the same sponsor.
- NCT03972449 — Beatboxing and Residual Speech Errors · NA · withdrawn
- NCT06247696 — Sweet Scents to Sweet Dreams · NA · completed
- NCT06173700 — Empowering Parental Caregivers · NA · completed
- NCT05608109 — A Social Media Personalized Normative Feedback Intervention for Heavy Drinking College Students · NA · completed
- NCT04543084 — Home Program Practice for People With Language Disorders After Stroke · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03942471 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duquesne University
- Last refreshed: 8 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03942471.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing